These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14966043)

  • 1. Insulin induced increase in coronary flow reserve is abolished by dexamethasone in young men with uncomplicated type 1 diabetes.
    Laine H; Sundell J; Nuutila P; Raitakari OT; Luotolahti M; Rönnemaa T; Elomaa T; Koskinen P; Knuuti J
    Heart; 2004 Mar; 90(3):270-6. PubMed ID: 14966043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men.
    Laine H; Nuutila P; Luotolahti M; Meyer C; Elomaa T; Koskinen P; Rönnemaa T; Knuuti J
    J Clin Endocrinol Metab; 2000 May; 85(5):1868-73. PubMed ID: 10843167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of insulin and short-term hyperglycaemia on myocardial blood flow in young men with uncomplicated Type I diabetes.
    Sundell J; Laine H; Nuutila P; Rönnemaa T; Luotolahti M; Raitakari O; Knuuti J
    Diabetologia; 2002 Jun; 45(6):775-82. PubMed ID: 12107720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary flow reserve is reduced in young men with IDDM.
    Pitkänen OP; Nuutila P; Raitakari OT; Rönnemaa T; Koskinen PJ; Iida H; Lehtimäki TJ; Laine HK; Takala T; Viikari JS; Knuuti J
    Diabetes; 1998 Feb; 47(2):248-54. PubMed ID: 9519721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes.
    Iozzo P; Chareonthaitawee P; Rimoldi O; Betteridge DJ; Camici PG; Ferrannini E
    Diabetologia; 2002 Oct; 45(10):1404-9. PubMed ID: 12378381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity C-reactive protein and impaired coronary vasoreactivity in young men with uncomplicated type 1 diabetes.
    Sundell J; Rönnemaa T; Laine H; Raitakari OT; Luotolahti M; Nuutila P; Knuuti J
    Diabetologia; 2004 Nov; 47(11):1888-94. PubMed ID: 15565375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy.
    Stevens MJ; Dayanikli F; Raffel DM; Allman KC; Sandford T; Feldman EL; Wieland DM; Corbett J; Schwaiger M
    J Am Coll Cardiol; 1998 Jun; 31(7):1575-84. PubMed ID: 9626837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic background retinopathy is associated with impaired coronary vasoreactivity in people with Type 1 diabetes.
    Sundell J; Janatuinen T; Rönnemaa T; Raitakari OT; Toikka J; Nuutila P; Knuuti J
    Diabetologia; 2004 Apr; 47(4):725-31. PubMed ID: 15298350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of type 2 diabetes on nitric oxide and adrenergic modulation of myocardial perfusion.
    Madsen MM; Søndergaard HM; Bøttcher M; Buus NH; Schmitz O; Bøtker HE; Nielsen TT
    Diabetes; 2007 Feb; 56(2):468-75. PubMed ID: 17259393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction.
    Pop-Busui R; Kirkwood I; Schmid H; Marinescu V; Schroeder J; Larkin D; Yamada E; Raffel DM; Stevens MJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2368-74. PubMed ID: 15607400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity affects myocardial vasoreactivity and coronary flow response to insulin.
    Sundell J; Laine H; Luotolahti M; Kalliokoski K; Raitakari O; Nuutila P; Knuuti J
    Obes Res; 2002 Jul; 10(7):617-24. PubMed ID: 12105283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients.
    Johansson BL; Sundell J; Ekberg K; Jonsson C; Seppänen M; Raitakari O; Luotolahti M; Nuutila P; Wahren J; Knuuti J
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E14-9. PubMed ID: 12954595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of diabetic men with erectile dysfunction to determine coronary flow reserve (CFR) and cardiac risk under medication with sildenafil (Viagra)].
    Merkle W; Dietz U; Jaursch-Hancke C
    Aktuelle Urol; 2004 Jun; 35(3):222-7. PubMed ID: 15258856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice.
    Labazi H; Teng B; Zhou Z; Mustafa SJ
    J Mol Cell Cardiol; 2016 Jan; 90():30-7. PubMed ID: 26654777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nitroglycerine on coronary flow velocity before and during adenosine provocation.
    Wittfeldt A; Jeppsson A; Gan LM
    Cardiovasc Ultrasound; 2016 Dec; 14(1):48. PubMed ID: 27919286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between insulin resistance and reduced coronary vasoreactivity in healthy subjects.
    Sundell J; Luotolahti M
    Can J Cardiol; 2004 May; 20(7):691-5. PubMed ID: 15197421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between retinopathy, microalbuminuria and coronary perfusion in young patients with type 1 diabetes mellitus.
    Dankowski R; Wierzchowiecki M; Naskret D; Michalski M; Kandziora M; Biegalski W; Poprawski K
    Kardiol Pol; 2008 Mar; 66(3):262-8. PubMed ID: 18393113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus.
    Srinivasan M; Herrero P; McGill JB; Bennik J; Heere B; Lesniak D; Davila-Roman VG; Gropler RJ
    J Am Coll Cardiol; 2005 Jul; 46(1):42-8. PubMed ID: 15992633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist.
    Kawata T; Daimon M; Hasegawa R; Teramoto K; Toyoda T; Sekine T; Yamamoto K; Uchida D; Himi T; Yoshida K; Komuro I
    Am Heart J; 2006 Apr; 151(4):798.e9-15. PubMed ID: 16569537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dysfunction of the coronary microcirculation in type 2 diabetic patients].
    Nitenberg A; Ledoux S; Valensi P; Sachs R; Attali JR; Antony I
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):937-41. PubMed ID: 10989733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.